Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYSLTR2 | Q9NS75 | 2/20 | 0.50 |
| ▸ | CYSLTR1 | Q9Y271 | 2/20 | 0.50 |
| ▸ | PPARA | Q07869 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.42 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.41 |
| ▸ | TLR4 | O00206 | 1/20 | 0.40 |
| ▸ | TLR2 | O60603 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.38 |
| ▸ | PTGIR | P43119 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17138154 | 1.00 | CYSLTR2 (0.50) | CYSLTR2CYSLTR1PPARATSHRAOC3 | |
| SCHEMBL17138207 | 0.89 | AOC3 (0.44) | CYSLTR2CYSLTR1PPARATSHRAOC3 | |
| SCHEMBL17138209 | 0.89 | AOC3 (0.44) | CYSLTR2CYSLTR1PPARATSHRAOC3 | |
| SCHEMBL3770949 | 0.86 | APP (0.46) | CYSLTR2CYSLTR1PPARATSHRKMT2A | |
| SCHEMBL3770953 | 0.86 | PPARA (0.50) | CYSLTR2CYSLTR1PPARATSHRAOC3 | |
| SCHEMBL3659366 | 0.86 | APP (0.46) | CYSLTR2CYSLTR1PPARATSHRKMT2A | |
| SCHEMBL3764501 | 0.82 | CYSLTR2 (0.48) | CYSLTR2CYSLTR1PPARATSHRPPARG | |
| SCHEMBL3764504 | 0.82 | PPARA (0.55) | CYSLTR2CYSLTR1PPARATSHRAOC3 | |
| SCHEMBL3663177 | 0.82 | CYSLTR2 (0.48) | CYSLTR2CYSLTR1PPARATSHRPPARG | |
| SCHEMBL17138220 | 0.81 | AOC3 (0.47) | CYSLTR2CYSLTR1TSHRAOC3GPBAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150283051-A1 | DERIVATIVE OF NOVEL POLYHYDROXY AROMATIC COMPOUND AND USE THEREOF | RNS CO.,LTD. (KR) | 2015-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150283051-A1 | DERIVATIVE OF NOVEL POLYHYDROXY AROMATIC COMPOUND AND USE THEREOF | HRH3, CBR3, H1-0 | CYSLTR2 1464/4885CYSLTR1 1220/4885PPARA 1509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.